151 related articles for article (PubMed ID: 31790893)
1. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
[TBL] [Abstract][Full Text] [Related]
2. Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.
Sakunrangsit N; Ketchart W
Eur J Pharmacol; 2020 Feb; 868():172878. PubMed ID: 31863768
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation.
Sakunrangsit N; Kalpongnukul N; Pisitkun T; Ketchart W
Phytother Res; 2016 Dec; 30(12):1968-1977. PubMed ID: 27530731
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt/β-catenin pathway in endocrine resistant breast cancer.
Sakunrangsit N; Ketchart W
Pharmacol Res; 2019 Dec; 150():104517. PubMed ID: 31693936
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer.
Fiorillo M; Sotgia F; Sisci D; Cappello AR; Lisanti MP
Oncotarget; 2017 Mar; 8(12):20309-20327. PubMed ID: 28411284
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
Xue D; Zhou X; Qiu J
J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
Yao Y; Brodie AM; Davidson NE; Kensler TW; Zhou Q
Breast Cancer Res Treat; 2010 Nov; 124(2):585-91. PubMed ID: 20623181
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
10. Plumbagin Triggers ER Stress-Mediated Apoptosis in Prostate Cancer Cells via Induction of ROS.
Huang H; Xie H; Pan Y; Zheng K; Xia Y; Chen W
Cell Physiol Biochem; 2018; 45(1):267-280. PubMed ID: 29357323
[TBL] [Abstract][Full Text] [Related]
11. Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer.
Chonsut P; Mahalapbutr P; Pradubyat N; Chavasiri W; Wonganan P; Ketchart W
J Pharm Pharmacol; 2019 Dec; 71(12):1839-1853. PubMed ID: 31588558
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
[TBL] [Abstract][Full Text] [Related]
13. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
Jordan NJ; Dutkowski CM; Barrow D; Mottram HJ; Hutcheson IR; Nicholson RI; Guichard SM; Gee JM
Breast Cancer Res; 2014 Jan; 16(1):R12. PubMed ID: 24457069
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation.
Kawiak A; Domachowska A; Jaworska A; Lojkowska E
Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.
Jiang M; Huang O; Zhang X; Xie Z; Shen A; Liu H; Geng M; Shen K
Molecules; 2013 Jan; 18(1):701-20. PubMed ID: 23299550
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells.
Chaisit S; Jianmongkol S
Biol Pharm Bull; 2021; 44(9):1239-1246. PubMed ID: 34471052
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
[TBL] [Abstract][Full Text] [Related]
18. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
